Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The EPIC-15 trial will evaluate the safety, pharmacokinetics, acceptability, and efficacy of pediatric ivermectin (CHILD-IVITAB) in scabies infected children weighing 5 to less than 15 kg. This trial will support future efforts to expand the indication of ivermectin treatment to infants weighing 5 to less than 15 kg to treat numerous NTDs, allowing this young age group equitable access to the numerous benefits of pediatric ivermectin therapy
Epistemonikos ID: 6f3b740aee9905ba57689164edfbaea83b10a2a6
First added on: Mar 22, 2025